SCHEMBL165385

SCHEMBL165385

CCS(=O)(=O)c1ccc(OC(C)=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.69
MAPT P10636 2/20 0.69
PKM P14618 1/20 0.69
LMNA P02545 3/20 0.53
ALDH1A1 P00352 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
KMT2A Q03164 3/20 0.50
PTGS2 P35354 2/20 0.50
MEN1 O00255 2/20 0.50
GAA P10253 2/20 0.50
HTT P42858 2/20 0.50
KDM4E B2RXH2 1/20 0.47
TTR P02766 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
ELANE P08246 2/20 0.47
PSIP1 O75475 2/20 0.47
HSD17B10 Q99714 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7724548 0.89 POLB (0.69) POLBMAPTPKMLMNAALDH1A1
SCHEMBL2652681 0.87 POLB (0.62) POLBMAPTPKMLMNAALDH1A1
SCHEMBL9422194 0.84 POLB (0.59) POLBMAPTPKMLMNAALDH1A1
SCHEMBL29323749 0.82 ELANE (0.51) POLBMAPTPKMLMNAALDH1A1
SCHEMBL9343618 0.82 PKM (1.00) POLBMAPTPKMLMNAALDH1A1
SCHEMBL14024262 0.82 MAPT (0.77) POLBMAPTPKMLMNAALDH1A1
SCHEMBL11576441 0.80 MMP2 (0.60) POLBMAPTPKMLMNAALDH1A1
SCHEMBL3161812 0.80 MAPT (0.74) POLBMAPTPKMLMNAALDH1A1
SCHEMBL1930857 0.80 MAPT (0.74) POLBMAPTPKMLMNAALDH1A1
SCHEMBL13133214 0.79 PKM (0.77) POLBMAPTPKMLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112135611-A Benzimidazole derivatives as modulators of retinoic acid-related orphan receptor gamma (ROR γ) and pharmaceutical uses thereof 江苏恒瑞医药股份有限公司 2020-12-25 CN disclosed
CN-109206346-A Tertiary amine analog derivative or its salt and its preparation method and application 复旦大学 2019-01-15 CN disclosed
WO-2018185675-A1 SUBSTITUTED OXOAZETIDINE ANALOGUES AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2018-10-11 WO disclosed
CN-106187838-B Aryl alkynes compound and its preparation method and application 广东东阳光药业有限公司 2018-05-01 CN disclosed
WO-2017199103-A1 BENZAMIDE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-11-23 WO disclosed
EP-3131880-A1 ARYL AND HETEROARYL ETHER COMPOUNDS AS ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2017-02-22 EP disclosed
CN-106232582-A Aryl and heteroaryl ether compound as ROR gamma modulators 格兰马克药品股份有限公司 2016-12-14 CN disclosed
CN-106187838-A Arylalkyne hydrocarbon compound and its production and use 广东东阳光药业有限公司 2016-12-07 CN disclosed
WO-2015159233-A1 ARYL AND HETEROARYL ETHER COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-10-22 WO disclosed
WO-2013171729-A2 ARYL AND HETEROARYL AMIDE COMPOUNDS AS RORGAMAT MODULATOR GLENMARK PHARMACEUTICALS S.A. (CH) 2013-11-21 WO disclosed
WO-2013029338-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2013-03-07 WO disclosed
WO-2012100734-A1 COMPOUNDS USEFUL AS RETINOID-RELATED ORPHAN RECEPTOR GAMMA MODULATORS GLAXO GROUP LIMITED (GB) 2012-08-02 WO disclosed
WO-2012100732-A1 RETINOID-RELATED ORPHAN RECEPTOR GAMMA MODULATORS, COMPOSITION CONTAINING THEM AND USES THEREOF GLAXO GROUP LIMITED (GB) 2012-08-02 WO disclosed
WO-2012028100-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-08 WO disclosed
WO-2012027965-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2012-03-08 WO disclosed